I

Disc Medicine
D

IRON

74.580
USD
-0.48
(-0.64%)
Market Closed
Last updated: · Delayed 15 min
Volume
44,530
EPS
-7
Div Yield
-
P/E
-11
Market Cap
3,310,818,306
Overview
Related Instruments
AA
AA
D
Alcoa Corp
37.920
-0.760(-1.96%)
BHP
BHP
D
BHP Group Limited
77.877
0.297(0.38%)
C
CLF
D
Cleveland-Cliffs
13.900
0.855(6.55%)
FCX
FCX
D
Freeport-McMoran
65.190
0.630(0.98%)
NUE
NUE
D
Nucor Corp
258.10
0.03(0.01%)
RIO
RIO
D
Rio Tinto plc
83.420
-0.670(-0.80%)
STLD
STLD
D
Steel Dynamics
241.530
1.647(0.69%)
VALE
VALE
D
Vale SA
12.400
0.215(1.76%)
More

Title: Disc Medicine

Sector: Healthcare
Industry: Biotechnology
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.